ADMA Biologics, Inc. Stock Prediction
AI-powered sentiment analysis and prediction trends for ADMA, updated each market day.
ADMA AI Sentiment
AI sees no strong directional signal for ADMA Biologics, Inc. stock over the next 10 market days.
Prediction date: Sept. 21, 2026
Exact scores are in the SharePreds app
The precise prediction score for this stock, with buy and sell targets and a stop loss, updated every market day.
About ADMA Biologics, Inc.
ADMA Biologics Inc is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing, and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases. The segments of the company are ADMA BioManufacturing, which generates maximum revenue, Plasma Collection Centres, and the corporate segment. The company sells plasma-derived intermediate fractions to certain customers, which are generated as part of its FDA-approved manufacturing process for IG and IVIG products. It also provides laboratory contracting services to certain customers and anticipates providing contract filling, labeling & packing services. The company derives maximum revenue from the United States.
Sector
Exchange
Market Cap
$2,004,662,885
Cap Tier
Employees
647
Headquarters
RAMSEY, NJ
Listed Since
Oct. 17, 2013
Website
ADMA Sentiment Trend: Last 30 Predictions
Sentiment zones: Bullish · Neutral · Bearish
ADMA Volatility
ADMA Biologics, Inc. has shown high price volatility over the last 5 trading days. High volatility means larger price swings: this can present both opportunity and risk for traders.
